Literature DB >> 8787674

Activation of human B cells by phosphorothioate oligodeoxynucleotides.

H Liang1, Y Nishioka, C F Reich, D S Pisetsky, P E Lipsky.   

Abstract

To investigate the potential of DNA to elicit immune responses in man, we examined the capacity of a variety of oligodeoxynucleotides (ODNs) to stimulate highly purified T cell-depleted human peripheral blood B cells. Among 47 ODNs of various sequences tested, 12 phosphorothioate oligodeoxynucleotides (sODNs) induced marked B cell proliferation and Ig production. IL-2 augmented both proliferation and production of IgM, IgG, and IgA, as well as IgM anti-DNA antibodies, but was not necessary for B cell stimulation. Similarly, T cells enhanced stimulation, but were not necessary for B cell activation. After stimulation with the active sODNs, more than 95% of B cells expressed CD25 and CD86. In addition, B cells stimulated with sODNs expressed all six of the major immunoglobulin VH gene families. These results indicate that the human B cell response to sODN is polyclonal. Active sODN coupled to Sepharose beads stimulated B cells as effectively as the free sODN, suggesting that stimulation resulted from engagement of surface receptors. These data indicate that sODNs can directly induce polyclonal activation of human B cells in a T cell-independent manner by engaging as yet unknown B cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787674      PMCID: PMC507533          DOI: 10.1172/JCI118894

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Monoclonal antibodies defining distinctive human T cell surface antigens.

Authors:  P Kung; G Goldstein; E L Reinherz; S F Schlossman
Journal:  Science       Date:  1979-10-19       Impact factor: 47.728

2.  The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells.

Authors:  U Galili; M Schlesinger
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

3.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

Review 4.  Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

Review 5.  The chemistry and biology of left-handed Z-DNA.

Authors:  A Rich; A Nordheim; A H Wang
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

6.  Immunoglobulin recognition of synthetic and natural left-handed Z DNA conformations and sequences.

Authors:  D A Zarling; D J Arndt-Jovin; M Robert-Nicoud; L P McIntosh; R Thomae; T M Jovin
Journal:  J Mol Biol       Date:  1984-07-05       Impact factor: 5.469

7.  Monocyte dependence of pokeweed mitogen-induced differentiation of immunoglobulin-secreting cells from human peripheral blood mononuclear cells.

Authors:  S A Rosenberg; P E Lipsky
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

8.  Regulation of cellular function by products of lysosomal enzyme activity: elimination of human natural killer cells by a dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocytes.

Authors:  D L Thiele; P E Lipsky
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

9.  Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester.

Authors:  D L Thiele; M Kurosaka; P E Lipsky
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

10.  Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus.

Authors:  A McCoubrey-Hoyer; T B Okarma; H R Holman
Journal:  Am J Med       Date:  1984-07       Impact factor: 4.965

View more
  56 in total

Review 1.  The influence of base sequence on the immunostimulatory properties of DNA.

Authors:  D S Pisetsky
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  A role for NF-kappaB-dependent gene transactivation in sunburn.

Authors:  K Abeyama; W Eng; J V Jester; A A Vink; D Edelbaum; C J Cockerell; P R Bergstresser; A Takashima
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 3.  The response of human B lymphocytes to oligodeoxynucleotides.

Authors:  H Liang; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 4.  Signal transduction induced by immunostimulatory CpG DNA.

Authors:  A M Krieg
Journal:  Springer Semin Immunopathol       Date:  2000

Review 5.  Introduction to immunostimulatory DNA sequences.

Authors:  J Van Uden; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

Review 6.  Mechanisms of immune stimulation by bacterial DNA.

Authors:  D S Pisetsky
Journal:  Springer Semin Immunopathol       Date:  2000

Review 7.  Pre-priming: a novel approach to DNA-based vaccination and immunomodulation.

Authors:  H Kobayashi; A A Horner; E Martin-Orozco; E Raz
Journal:  Springer Semin Immunopathol       Date:  2000

8.  'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents.

Authors:  Dong Yu; Ekambar R Kandimalla; Lakshmi Bhagat; Jin-Yan Tang; Yanping Cong; Jimmy Tang; Sudhir Agrawal
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

9.  The use of CpG as an adjuvant to Toxoplasma gondii vaccination.

Authors:  Jennifer A Spencer; Bruce F Smith; Anthony J Guarino; Byron L Blagburn; Henry J Baker
Journal:  Parasitol Res       Date:  2004-01-15       Impact factor: 2.289

10.  Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Authors:  Jörg Vollmer; Risini D Weeratna; Marion Jurk; Ulrike Samulowitz; Michael J McCluskie; Paul Payette; Heather L Davis; Christian Schetter; Arthur M Krieg
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.